NATUREX : Ordinary and Extraordinary General Meeting 27 June 2011: Information available


Avignon, June 11, 2011 - Naturex, the world leader in specialty plant-based natural ingredients, informs its shareholders about the availability of the information relating to the Ordinary and Extraordinary General Meeting on June 27, 2011.

The shareholders of the Company are convened to the Ordinary and Extraordinary General Meeting:

Monday June 27, 2011 at 10:00 am
At Palais Brongniart - Petit Auditorium
Place de la Bourse - Entrée Rue Vivienne
75002 Paris

A notice including the agenda and the final text of the resolutions to be proposed to shareholders for approval was published in the Official Bulletin (BALO - Bulletin des Annonces Légales Obligatoires) and in a legal newspaper dated June 10, 2011. This notice amends the preliminary notice published in the Official Bulletin in May 20, 2011.

The documents provided by Article R.225-83 of the Commercial Law (Code de Commerce) are made available to shareholders after the convening of the meeting in accordance with the applicable regulations:

any registered shareholder may, until the fifth day inclusive before the meeting, ask the company to send these documents. For bearer shareholders the exercise of this right is subject to the provision of a certificate of the authorized intermediary stating that the bearer shares registered up until the date of the meeting are not available to be shown ; any shareholder may take note at the registered office of the Company during a period of 15 days preceding the date of the meeting.

All information on how to participate and vote at this General Meeting and a booklet including the documents specified in Article R.225-81 of the Commercial Law (Code de Commerce) are available on NATUREX website: (investors section> Documents> general meetings).

2010 Reference Document filed in April 28, 2011 with the French Financial Markets Authority (AMF - Autorité des Marchés Financiers) may also be viewed on the Company's website, including the annual financial report 2010 FY, under Article L 451-1 -2 of the Monetary and Financial Code Code monétaire et financier), the report on the organization of the board and internal control procedures and the statement concerning fees paid to auditors.

Receive free of charge by e-mail all financial information concerning NATUREX by registering on:

Next publications

1st half-year sales : 26 July 2011 1st half-year results : 31 August 2011

NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996

  Number of shares in the capital: 6,410,931

4,959,935 ordinary shares (ISIN FR0000054694) 1,450,996 preferred shares (ISIN FR0000010833251)

Naturex is part of the CAC Small and Gaïa Indexes.
Naturex is eligible for the "long-only" DSS.

MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP

About Naturex

Naturex is the global leader in specialty plant-based natural ingredients.

The Group is organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - and produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network of sales offices in 19 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).

Naturex's sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its positioning on specific products which constitute niche markets, thanks to strong sourcing capacity and sustained Research & Development.

Jacques Dikansky
President and CEO
Tel.: +33 (0)4 90 23 96 89
Thierry Lambert
Vice-President and CFO
Tel.: +33 (0)4 90 23 96 89
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
Anne Catherine Bonjour
Press Relations - Actus Finance
Tel.: +33 (0)1 53 67 36 93
Information réglementée
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition des documents préparatoires à l'AG Communiqué intégral et original au format PDF : © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur
Receive by email the next press releases of the company by registering on, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant